Abstract
Objective
To evaluate the impact of eye-tracking (ET) technology on optical coherence tomography angiography (OCT-A) image quality and manifestation of motion artifacts in patients with age-related macular degeneration (AMD).
Methods
In a prospective trial, multimodal retinal imaging including OCT-A was performed in 30 patients (78.97 ± 9.7 years) affected by different stages of AMD. Central 3 × 3 mm2 OCT-A imaging was performed four times consecutively in each patient, twice with active, and twice with inactive ET. Parameters for image evaluation were signal strength index (SSI), variability of foveal vessel density (VD), acquisition time, presence of motion artifacts caused by eye movement (blink lines, displacement) and by software correction of eye movement (quilting, stretch artifacts, vessel doubling). Images were evaluated by two independent readers with subsequent senior reader arbitration for presence of artifacts, and an OCT-A motion artifact score (MAS) was calculated.
Results
Eight patients had early and eight patients had intermediate stages of AMD. Four patients had an atrophic late stage and ten patients an exudative stage of the disease. SSI was 53.55 with inactive and 57.18 with active ET (p = 0.0005). Coefficients of variability of VD between the first and second measurement were 8.9% with inactive and 5.7% with active ET. Mean image acquisition time was 15.97 s (active ET: 22.88 s, p < 0.001). Presence of motion artifacts was significantly higher with inactive ET (mean MAS 3.27 vs. 1.93; p < 0.0001). MAS correlated with AMD disease stage [p = 0.0031 (inactive ET) and p < 0.0001 (active ET)] and with SSI (p = 0.0072 and p = 0.0006).
Conclusions
In patients with AMD, active ET technology offers an improved image quality in OCT-A imaging regarding presence of motion artifacts at the expense of higher acquisition time.
Similar content being viewed by others
References
Jia Y, Tan O, Tokayer J et al (2012) Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express 20:4710–4725
Jia Y, Bailey ST, Hwang TS et al (2015) Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye. Proc Natl Acad Sci U S A 112:E2395–E2402
Spaide RF, Fujimoto JG, Waheed NK et al (2015) Image artifacts in optical coherence tomography angiography. Retina 35:2163–2180
Ghasemi Falavarjani K, Al-Sheikh M, Akil H, Sadda SR (2016) Image artefacts in swept-source optical coherence tomography angiography. Br J Ophthalmol. doi:10.1136/bjophthalmol-2016-309104
Say EA, Ferenczy S, Magrath GN, Samara WA, Khoo CT, Shields CL (2016) Image quality and artifacts on optical coherence tomography angiography: comparison of pathologic and paired fellow eyes in 65 patients with unilateral choroidal melanoma treated with plaque radiotherapy. Retina. doi:10.1097/IAE.0000000000001414
Kanagasingam Y, Bhuiyan A, Abràmoff MD, Smith RT, Goldschmidt L, Wong TY (2014) Progress on retinal image analysis for age-related macular degeneration. Prog Retin Eye Res 38:20–42
Coscas GJ, Lupidi M, Coscas F, Cagini C, Souied EH (2015) Optical coherence tomography angiography versus traditional multimodal imaging in assessing the activity of exudative age-related macular degeneration: a new diagnostic challenge. Retina 35:2219–2228
Ho J, Sull AC, Vuong L et al (2009) Assessment of artifacts and reproducibility across spectral- and time-domain optical coherence tomography devices. Ophthalmology 116:1960–1970
Sadda SR, Wu Z, Walsh AC et al (2006) Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology 113:285–293
Asrani S, Essaid L, Alder BD, Santiago-Turla C (2014) Artifacts in spectral-domain optical coherence tomography measurements in glaucoma. JAMA Ophthalmol 132:396–402
Song Y, Lee BR, Shin YW, Lee YJ (2014) Overcoming segmentation errors in measurements of macular thickness made by spectral domain optical coherence tomography. Retina 32:569–580
Kraus MF, Potsaid B, Mayer MA et al (2012) Motion correction in optical coherence tomography volumes on a per A-scan basis using orthogonal scan patterns. Biomed Opt Express 3(6):1182–1199
Camino A, Zhang M, Gao SS et al (2016) Evaluation of artifact reduction in optical coherence tomography angiography with real-time tracking and motion correction technology. Biomed Opt Express 7(10):3905–3915
Camino A, Zhang M, Dongye C, Pechauer AD, Hwang TS, Bailey ST, Lujan B, Wilson DJ, Huang D, Jia Y (2016) Automated registration and enhanced processing of clinical optical coherence tomography angiography. Quant Imaging Med Surg 6(4):391–401
You Q, Freeman WR, Weinreb RN et al (2016) Reproducibility of vessel density measurement with optical coherence tomography angiography with and without retinopathy. Retina. doi:10.1097/IAE.0000000000001407
Cole ED, Ferrara D, Novais EA, Louzada RN, Waheed NK (2016) Clinical trial endpoints for optical coherence tomography angiography in neovascular age-related macular degeneration. Retina 36(Suppl 1):S83–S92
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Author disclosure information
J. L. Lauermann, none; M. Treder, Allergan, Novartis; P. Heiduschka, Bayer, Novartis; C.R. Clemens, Heidelberg Engineering, Novartis, Bayer; N. Eter, Heidelberg Engineering, Novartis, Bayer, Sanofi Aventis, Allergan, Bausch and Lomb; F. Alten, Bayer.
Funding
No funding was received for this research.
Conflict of interest
All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Lauermann, J.L., Treder, M., Heiduschka, P. et al. Impact of eye-tracking technology on OCT-angiography imaging quality in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 255, 1535–1542 (2017). https://doi.org/10.1007/s00417-017-3684-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-017-3684-z